These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36064286)

  • 41. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
    Hughes RJ; Sack RL; Lewy AJ
    Sleep; 1998; 21(1):52-68. PubMed ID: 9485533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
    Van der Heijden KB; Smits MG; Van Someren EJ; Ridderinkhof KR; Gunning WB
    J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):233-41. PubMed ID: 17242627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin in circadian sleep disorders in the blind.
    Skene DJ; Lockley SW; Arendt J
    Biol Signals Recept; 1999; 8(1-2):90-5. PubMed ID: 10085469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulatory aspects and evidences of melatonin use for sleep disorders and insomnia: an integrative review.
    Bueno APR; Savi FM; Alves IA; Bandeira VAC
    Arq Neuropsiquiatr; 2021 Aug; 79(8):732-742. PubMed ID: 34550191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of melatonin in the treatment of phase shift and sleep disorders.
    Skene DJ; Lockley SW; Arendt J
    Adv Exp Med Biol; 1999; 467():79-84. PubMed ID: 10721041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy.
    Leger D; Laudon M; Zisapel N
    Am J Med; 2004 Jan; 116(2):91-5. PubMed ID: 14715322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improvement of sleep quality in elderly people by controlled-release melatonin.
    Garfinkel D; Laudon M; Nof D; Zisapel N
    Lancet; 1995 Aug; 346(8974):541-4. PubMed ID: 7658780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Disturbed sleep in children with ADHD: is there a place for melatonin as a treatment option?].
    Holvoet E; Gabriëls L
    Tijdschr Psychiatr; 2013; 55(5):349-57. PubMed ID: 23696337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.
    Weiss MD; Wasdell MB; Bomben MM; Rea KJ; Freeman RD
    J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):512-519. PubMed ID: 16670647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R
    Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.
    Laudon M; Frydman-Marom A
    Int J Mol Sci; 2014 Sep; 15(9):15924-50. PubMed ID: 25207602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric sleep disturbances and treatment with melatonin.
    Esposito S; Laino D; D'Alonzo R; Mencarelli A; Di Genova L; Fattorusso A; Argentiero A; Mencaroni E
    J Transl Med; 2019 Mar; 17(1):77. PubMed ID: 30871585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of melatonin in selected populations of sleep-disturbed patients.
    Brusco LI; Fainstein I; Márquez M; Cardinali DP
    Biol Signals Recept; 1999; 8(1-2):126-31. PubMed ID: 10085474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind.
    Emens JS; Eastman CI
    Drugs; 2017 Apr; 77(6):637-650. PubMed ID: 28229310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Some implications of melatonin use in chronopharmacology of insomnia.
    Golombek DA; Pandi-Perumal SR; Brown GM; Cardinali DP
    Eur J Pharmacol; 2015 Sep; 762():42-8. PubMed ID: 26004526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered circadian melatonin secretion patterns in relation to sleep in patients with chronic sleep-wake rhythm disorders.
    Rodenbeck A; Huether G; Rüther E; Hajak G
    J Pineal Res; 1998 Dec; 25(4):201-10. PubMed ID: 9885989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacotherapies for sleep disturbances in dementia.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nocturnal melatonin secretion and its modification by treatment in patients with sleep disorders.
    Rodenbeck A; Huether G; Rüther E; Hajak G
    Adv Exp Med Biol; 1999; 467():89-93. PubMed ID: 10721043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of treatment with melatonin on primary school aged children with difficulty in initiation and maintenance of sleep.
    Jalilolghadr S; Roozmehr S; Yazdi Z; Soltanabadi M
    Turk J Pediatr; 2022; 64(6):993-1000. PubMed ID: 36583881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.